Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001562180-24-000338

President, CMO gave up 3,844 shares (to pay taxes)

  • President, CMO acquired 9,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huang Jane President, CMO 2024-01-04 Option exercise +9,375 49,103 D
Huang Jane President, CMO 2024-01-04 Shares withheld for taxes −3,844 $3.77 $14,492 45,259 D
Derivatives
Huang Jane President, CMO 2024-01-04 Option exercise · Restricted Stock Unit −9,375 84,375 D
Loading xslF345X05/primarydocument.xml…